Abstract:Alzheimer's disease (AD) is a most common and prevalent age related insidious neurological condition characterised by formation of Aβ (1-42) plaques and NFT in the hippocampus. Major symptoms of AD include memory and cognitive loss caused by neuroinflammation, Aβ (1-42) plaques, and NFT accumulation in the brain. Intracerebroventricular administration of STZ up-regulates the level of Aβ (1-42) plaques, and NFT by activating NF-kB pathway. All animals were trained for behaviour analysis before infusion of ICV-STZ bilaterally, at a dose of 3 mg/kg; icv. The stereotaxic surgery was performed in target region with coordinates -2 mm [AP], 1.6 mm [MR], and1.5 mm [DV]. On day 1 and day 3 after surgery HS (hamilton syringe) was used to infuse STZ at the target region of brain. Morris Water Maze (MWM), and Elevated Plus Maze (EPM) tests were performed to check spatial and learning memory in all groups. ICV-STZ infusion produced memory impairment by increasing the activity of AchE, oxidative markers (LPO, GSH, and nitrite), neurotransmitters levels (AchE, GABA, and glutamate), and release of neuroinflammatory markers (NF-kB, IL-6, and IL-1β). The treatment with Honokiol (Bioactive polyphenolic compound) significantly ameliorated the behavioural changes at a dose of 5, and 10 mg/kg; i.p on day 7, 14, and 21. After behavioural analysis rats were sacrificed on day 22, and the hippocampus tissue was collected to investigate the biochemical, neuroinflammatory, neurotransmitters, histopathological, and immunohistopathological changes. Here, we have found Honokiol significantly down regulates the Aβ plaques via NF-kB inhibition and also reduced neuroinflammation in the brain of rats. Further inhibits the NF-kB expression confirmed for immunohistochemistry analysis. It was observed that Honokiol (5, and 10 mg/kg; i.p) dose-dependently ameliorated AchE level restored neurotransmitters concentrations in hippocampal region, and prevented neuronal loss confirmed from histopathology studies. We concluded that Honokiol drastically produced protective effect in AD model via antioxidant, reducing inflammation, AchE level, restoration of neurofibrillary tangles and preventing NF-kB as well as histopathological changes.

Honokiol Inhibits the Inflammatory Reaction During Cerebral Ischemia Reperfusion by Suppressing NF-κB Activation and Cytokine Production of Glial Cells.

Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress

Honokiol: an effective inhibitor of tumor necrosis factor-α-induced up-regulation of inflammatory cytokine and chemokine production in human synovial fibroblasts

Honokiol Ameliorates Focal Cerebral Ischemia and Enhances Tissue Reactive Oxygen Species Scavenging Capacity after Cerebral Ischemia-Reperfusion

Honokiol Protects Brain Against Ischemia–reperfusion Injury in Rats Through Disrupting PSD95–nNOS Interaction

Inhibitory Effects of Honokiol on Lipopolysaccharide-Induced Cellular Responses and Signaling Events in Human Renal Mesangial Cells

Minocycline Reduces Intracerebral Hemorrhage-Induced Brain Injury

Honokiol: an Effective Inhibitor of High-Glucose-Induced Upregulation of Inflammatory Cytokine Production in Human Renal Mesangial Cells

Honokiol Protects Brain Against Global Brain Ischemia in Mice Through Inhibiting MPTP Opening and PARP-1 Activity

Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation.

Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ (1-42) and NF-kB expression in experimental model of rats

HH-A, a modified honokiol, protects against cerebral ischemia/reperfusion induced brain injury in rodent via Nrf2/HO-1 signaling pathways

Honokiol Reduces Mitochondrial Dysfunction and Inhibits Apoptosis of Nerve Cells in Rats with Traumatic Brain Injury by Activating the Mitochondrial Unfolded Protein Response

Effect of Honokiol on TXB2,6 - Keto - PGF1α,ET,NO after Global Cere-bral Ischemia - Reperfusion Injury in Dog

Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro

Honokiol prevents chronic cerebral hypoperfusion induced astrocyte A1 polarization to alleviate neurotoxicity by targeting SIRT3-STAT3 axis

AKG Attenuates Cerebral Ischemia-Reperfusion Injury through c-Fos/IL-10/Stat3 Signaling Pathway

Honokiol Up-Regulates Prostacyclin Synthease Protein Expression and Inhibits Endothelial Cell Apoptosis.

Nerolidol Attenuates Cerebral Ischemic Injury in Middle Cerebral Artery Occlusion-Induced Rats via Regulation of Inflammation, Apoptosis, and Oxidative Stress Markers

Inhibition of NF-κB Activation is Associated with Anti-Inflammatory and Anti-Apoptotic Effects of Ginkgolide B in a Mouse Model of Cerebral Ischemia/reperfusion Injury

Ameliorative effects of Diammonium Glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury